Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Lisata Therapeutics, Inc. (LSTA) had Weighted-Average Shares Outstanding (Diluted) of 8.60M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-4.72M |
|
-- |
|
-- |
|
$5.85M |
|
$-5.85M |
|
$0.16M |
|
$-5.69M |
|
$-5.69M |
|
$-4.72M |
|
$-4.72M |
|
$-4.72M |
|
$-4.72M |
|
$-5.85M |
|
$-5.84M |
|
8.60M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
8.60M |
$-0.55 |
|
$-0.55 |
|
| Balance Sheet Financials | |
$28.62M |
|
$0.07M |
|
$0.36M |
|
$28.98M |
|
$3.81M |
|
-- |
|
$0.07M |
|
$3.88M |
|
$25.10M |
|
$24.93M |
|
$25.10M |
|
8.62M |
|
| Cash Flow Statement Financials | |
$-5.40M |
|
$9.43M |
|
$-0.02M |
|
$16.21M |
|
$20.22M |
|
$4.01M |
|
$0.53M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.52 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-5.43M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-18.82% |
|
-18.95% |
|
-16.30% |
|
-18.82% |
|
$2.91 |
|
$-0.63 |
|
$-0.63 |
|